| 摘要 |
The present invention relates to compounds described herein Formula (I) and pharmaceutical acceptable salts thereof, which modulate the activity of calcium release-activated calcium (CRAC) channel. The invention also describes the compounds of Formula (I) and pharmaceutical compositions containing such compounds thereof for treating, managing, and/or lessening the severity of diseases, disorders, syndromes or conditions associated with the modulation of calcium release-activated calcium (CRAC) channel. |
| 申请人 |
LUPIN LIMITED |
发明人 |
IRLAPATI, NAGESWARA, RAO;SHAIKH, ZUBAIR, ABDUL WAJID;KARCHE, VIJAY, PANDURANG;DESHMUKH, GOKUL, KERUJI;SINHA, NEELIMA;PALLE, VENKATA, P.;KAMBOJ, RAJENDER, KUMAR |
